Next Article in Journal
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
Next Article in Special Issue
Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis
Previous Article in Journal
Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy
Previous Article in Special Issue
Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
 
 

Order Article Reprints

Journal: Pharmaceutics, 2022
Volume: 14
Number: 2753

Article: OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
Authors: by Ana Maria Lé and Tiago Torres
Link: https://www.mdpi.com/1999-4923/14/12/2753

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop